Inventor · disambiguated record
Adam James Davenport
Also filed as: DAVENPORT ADAM · DAVENPORT ADAM JAMES
12 granted patents·10 pending applications·18 citations·filing 2007–2023
85Inventor score
Top patents by PatentIndex Score
22 records- 0190US10202369B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Feb 12, 2019·4 cites·26 claims
- 0289US10472354B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2018·Granted Nov 12, 2019·3 cites·13 claims
- 0389US10174016B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2015·Granted Jan 8, 2019·4 cites·34 claims
- 0486US11142523B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2019·Granted Oct 12, 2021·2 cites·16 claims
- 0581US10183937B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Jan 22, 2019·4 cites·22 claims
- 0673US2023053411A11,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2021·Application pending·0 cites
- 0772US11905270B2Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptorBayer Pharma AG·Filed 2017·Granted Feb 20, 2024·1 cites·3 claims
- 0868US12239630B2Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptorBayer Pharma AG·Filed 2023·Granted Mar 4, 2025·0 cites·3 claims
- 0966US12023319B2Carboxylic acid aromatic amidesBayer Pharma AG·Filed 2021·Granted Jul 2, 2024·0 cites·5 claims
- 1055US2025289793A1Macrocyclic inhibitors of atp citrate lyaseESPERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1151US2024336574A1Methyl-substituted pyridine and pyridazine compounds, derivatives thereof, and methods of their useLATIGO BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1250US2011046130A1Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonistsEVOTEC AG·Filed 2009·Application pending·0 cites
- 1345US8349831B2Calcium receptor modulating agentsAMGEN INC·Filed 2007·Granted Jan 8, 2013·0 cites·10 claims
- 1442US2023271953A1Novel compounds for treatment of diseases related to DUX4 expressionFACIO INTELLECTUAL PROPERTY B V·Filed 2020·Application pending·0 cites
- 1542US2023052017A1New compounds for treatment of diseases related to DUX4 expressionFACIO INTELLECTUAL PROPERTY B V·Filed 2020·Application pending·0 cites
- 1640US11319324B2Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitorsBAYER AG·Filed 2018·Granted May 3, 2022·0 cites·11 claims
- 1740US2019177279A1Carboxylic acid aromatic 1,2-cyclopropylamidesBayer Pharma AG·Filed 2018·Application pending·0 cites
- 1840US2019194148A1Tetrazole-containing 1,2-cyclopropane-carboxamidesBayer Pharma AG·Filed 2018·Application pending·0 cites
- 1940US2019177284A1Tetrazolyl-containing cyclopropanecarboxamidesBayer Pharma AG·Filed 2018·Application pending·0 cites
- 2038US8691804B2Azetidines and cyclobutanes as histamine H3 receptor antagonistsDAVENPORT ADAM JAMES·Filed 2009·Granted Apr 8, 2014·0 cites·15 claims
- 2138US2021317092A1Tetrazole containing compoundsBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2226US8912176B2Azetidines as histamine H3 receptor antagonistsDAVENPORT ADAM JAMES·Filed 2010·Granted Dec 16, 2014·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Adam James Davenport files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →